NHS England has urged healthcare professionals to “focus on improving early recognition and timely treatment of sepsis.” Based on DNA Flow technology, the Sepsis Flow Chip can detect a wide range of pathogens and antibiotic resistant genes from patient blood cultures.

A revolutionary new rapid test to support clinicians in countering the threat of Antimicrobial Resistance (AMR) has been developed by the international biotechnology company Master Diagnostica and is being exclusively supplied in the UK through Oxford Biosystems.

• Host Cell Protein-HCP (E.coli) ELISA (launched 13 \ 10 \ 2016)
• Obestatin Mouse/Rat ELISA (launched 13 \ 10 \ 2016)